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Objective.The objective was to study the risk and protective factors involved in retinal vascular development of preterm infants with
retinopathy of prematurity.Methods. Between 2000 and 2017, 185 preterm infants were included in the protocol for retinopathy of
prematurity. Risk factors associated with speed of retinal vascularization <0.5 disc diameter/week were studied in each of them.
Results. The statistically significant variables related to retinal vascular development <0.5 DD/w were intubation days, degree 3 of
bronchopulmonary dysplasia, weight gain at 4-6 weeks, avascular temporal area, gestational age, number of transfusions, sepsis,
number of risk factors, apnea at birth, presence of ductus arteriosus, and days of continuous positive airway pressure therapy. After
the multivariate logistic regression analysis, only three variables were found to be significant: intubation days (p=0.005), degree
3 of bronchopulmonary dysplasia (p=0.022), and weight gain at 4–6 weeks (p=0.031). Conclusion. In retinopathy of prematurity,
degree 3 of bronchopulmonary dysplasia and intubation days cause delayed retinal vascular development, whereas greater postnatal
weight gain favors an appropriate rate of retinal vascularization.
1. Introduction
Retinopathy of prematurity (ROP) is a vasoproliferative dis-
ease of multifactorial etiology due to abnormal vasculariza-
tion of the retina. Themore advanced the stage of ROP is, the
more vascular and ischemic changes are found and therefore
more weeks are required for completion of vascularization
and subsequent involution [1]. Mintz measured the retinal
vascular development in disc diameters per week (DD/w).
The speed of vascularization was found to be lower in
patients with recurrent ROP than in thosewithout recurrence
[2].
The higher the stage of ROP is, the lower the speed
of vascularization will be. Preterm infants with delayed or
insufficient retinal vascularization have an increased risk for
ROP that can be treated with laser and/or anti-VEGF.
This risk increases when the temporal retinal vasculariza-
tion is lower than 0.5 disc diameter/week (DD/w) [3].
The purpose of this study was to analyze the risk and
protective factors associated with the speed of retinal vas-
cularization in those premature infants included in the ROP
protocol.
2. Material and Methods
Between 2000 and 2017 we explored a total of 612 premature
infants in San Cecilio University Hospital of Granada, Spain,
following our hospital protocol for ROP, of which 417 were
excluded from the sample because they did not meet the
inclusion criteria. A total of 185 babies were eligible to take
part in the study. Clinical data were collected retrospectively
from the inclusion of premature infants in said protocol to
the medical discharge. ROP was recorded according to the
International classification of ROP.
The inclusion criteria were the following: to be born
with a gestational age of ≤32 weeks, to undergo at least
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Table 1: Univariate analysis of factors that modify significantly the retinal vascular development: intubation days (d), BPD 3, weight gain
at 4-6 weeks (gr/days), avascular temporal area (DD), gestational age (weeks), sepsis, apnea at birth, ductus arteriosus, and CPAP therapy
(days).
Risk factor Odds ratio (CI 95%) P-value R2 Nagelkerke
Intubation days (d) 1.068 (1.03-1.10) <0.01 15.9%
BPD 3 1.57 (1.2-2.07) 0.01 8.6%
Weight gain (gr/day) 0.92 (0.86-0.97) 0.04 6.9%
Avascular temporal area 1.325 (1.1-1.59) 0.003 6.7%
Gestational age 0.79 (0.68-0.93) 0.04 6.2%
Transfusions number 1.80 (1.12-2.89) 0.015 4.9%
Sepsis 2.21 (1.19-4.1) 0.012 4.7%
Number of risk factors 1.14 (1.02-1.27) 0.024 3.9%
Apnea at birth 2.54 (1.12-5.75) 0.025 3.7%
Ductus arteriosus 2.36 (1.08-5.15) 0.032 3.4%
Days of CPAP therapy 1.05 (1.003-1.10) 0.039 3.2%
three examinations, and to be diagnosed with stages 1, 2,
or 3 of ROP. The exclusion criteria were < 3 explorations,
stages 4, 5, and aggressive ROP (APROP) (low number of
cases), opacity of means, and congenital ophthalmological or
systemic abnormalities [3].
The degree of retinopathy in each eye was determined
via indirect ophthalmoscopy with indentation and after
pharmacological mydriasis by an expert ophthalmologist in
this technique, using for this purpose a 20-diopter lens. This
lens provides amagnification of 2.5, allowing a 45∘ view of the
retina, the equivalent of 8 disc diameters. Speed of temporal
retinal vascularization (DD/w) was calculated as the ratio
between the extent of temporal retinal vascularization (DD)
and the time in weeks (w).The horizontal disc diameter (DD)
was used as a unit of length [3].
The speed of temporal retinal vascularization <0.5 DD/w
was considered a dependent variable. Predictive factors
included intubation days, presence or absence of degree 3 of
dysplasia bronchopulmonary (BPD 3), weight gain (gr/day)
at 4–6 weeks, avascular temporal retinal area (DD), gesta-
tional age (weeks), performance of transfusions, presence or
absence of sepsis, number of risk factors, presence or absence
of apnea at birth, patent ductus arteriosus, and days with
continuous positive airway pressure (CPAP) therapy.
Sepsis is defined as life-threatening organ dysfunction
caused by a dysregulated host response to infection [4]. All
the patients showed positive results in the fungal and/or bac-
terial culture as well as hematological disorders compatible
with sepsis.
Apnea is defined as cessation of breathing for at least 10
seconds; a duration of at least 20 seconds is frequently used
to diagnose significant apneas, as normal infants do not have
apneas of greater than 20 seconds [5].
BPD is a chronic lung disease that causes decreased
alveolar and capillary development, resulting in limitations
of the respiratory function [6, 7]. It can be classified into
three different severity grades. The presence of any degree of
BPD is recorded. According to the thresholds proposed by
NIHCD and by Jobe and Bancalari, BPD is defined as a need
for supplemental oxygen >21% at 28 days of life and/or a need
for supplemental oxygen >21% or for positive airway pressure
at 36 weeks’ corrected gestational age. BPD is classified as
mild, moderate, or severe [8, 9].
Between 2000 and 2017, oxygenation protocolsweremod-
ified.During the years 2000 and 2009 oxygen saturation levels
were maintained around 95%; from 2009 oxygen saturation
target decreased between 85 and 93% [10].
Statistical Package for Social Sciences (SPSS 15.0, Inc.,
Chicago, IL) was used for the statistical analysis. The data
were analyzed using descriptive statistics and 𝜒2 testing. Sub-
sequently, a binary logistic regression analysis was performed
to determine the risk factors influencing the vascularization
<0.5DD/w. Risk factors were analyzed through univariate
analysis and then by applying the bivariate logistic regression
model. The independent variables or risk factors considered
in our study are described in Table 1.The odds ratio (OR)with
95% CIs associated with each predictor was calculated from
logistic regression models.The final model obtained contains
risk factors with p<0.05.
3. Results
3.1. Demographic Characteristics of the Study Population.
From the total of 185 premature infants, there were 91 (49.2%)
males and 94 (50.8%) females. The mean gestational age and
birth weight were 28.95 weeks (SD 1.99) and 1119.35 gr (SD
270.94), respectively.
3.1.1. Risk Factors Leading to Speed of Temporal Retinal
Vascularization < 0.5 DD/w. A univariate analysis of factors
associated with speed of vascularization <0.5DD/w was
performed. Table 1 contains the risk factors considered to be
statistically significant after the analysis.
3.1.2. Binary Logistic Regression Analysis of Factors Asso-
ciated with Speed of Retinal Vascularization <0.5 DD/w
or ≥ 0.5 DD/w. According to the results of the logistic
regression, this model explains 22.5% of the variability of
data collected about the speed of vascularization of the
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Table 2: The multiple logistic regression analysis showed 3 independent risk factors leading to speed of vascularization <0.5 DD/w, which
were included in the model.
B Sig. Exp (B) 95% CI for EXP (B)
Intubation days 0.048 0.005 1.049 1.015 - 1.085
Weight gain - 0.069 0.031 0.933 0.876 – 0.994
BPD 3 0.808 0.022 2.244 1.123 – 4.483
Constant - 0.706 0.121 0.494
patients. Multiple stepwise regression analyses considered to
be reliable showed three independent risk factors associated
with delayed vascularization speed (Table 2): intubation days
[OR: 1.05 (CI: 1.015–1.085), p=0.005], BPD 3 [OR: 2.24 (CI:
1.12–4.48), p=0.022], and weight gain (gr/day) [OR: 0.93 (CI:
0.876–0.994), p=0.031].
The risk is calculated with the following formula:
Logit : −0.706 + 0.048 (intubation days) − 0.069 (weight gain) + 0.808 (BPD 3) .
Risk of temporal retinal vascularization < 0.5 DD/w = 1/1 + e−logit.
(1)
In the model, the factors that cause delayed retinal vascular-
ization in ROP are intubation days and presence of BPD 3.
However, weight gain at 4–6 weeks acts as a protective factor.
4. Discussion
In severe ROP there is a delay in retinal vascularization [2, 11].
Ashton estimates the normal speed of retinal vascularization
in the premature infants to be 0.1mm/day equivalent to 0.7
DD/w [12]. According to our results, premature infants with
a vascularization rate < 0.5 DD/w had a greater avascular area
at similar gestational age than those with vascularization ≥
0.5DD/w; this delay in vascularization significantly increased
the need for treatment [3].
Multiple factors have been identified to affect the devel-
opment of ROP, many of them related to inflammatory
mechanisms. Premature infants suffer from delayed retinal
vascular development. The delayed retinal vascular devel-
opment together with other risk factors such as intubation
days, BPD ≥ 3, low weight gain at 4-6 weeks, avascular
temporal retinal area, very low gestational age, performance
of transfusions, sepsis, apnea at birth, PDA, and days of
CPAP therapy increases the risk of suffering from severe ROP
[13].
The postnatal environment influences premature and
more immature infants for longer, adversely affecting the
development of retinal vascularization [14]. Other studies
describe blood transfusion, the presence of sepsis, apnea, and
ductus arteriosus as risk factors for severe ROP; in our work
we found statistically significant results for the same factors
[15, 16]. Low gestational age and lower birth weight have also
been described as predictors of abnormal retinal vasculariza-
tion [17]. Our results indicate that lower gestational age and
lower weight gain delay retinal vascularization.
According to theCRYO-ROPgroup, patientswith ROP in
zone I versus patients with ROP in zone II had a higher risk
of ROP with unfavourable structural results. The abnormal
formation of vessels is greater in those patients with greater
avascular area; this determines a delay in the rate of vascu-
larization [18]. The final stage of ROP was found to be less
severe when the speed of retinal vascularization was higher
[3]. Other authors also found a difference in the speed of
vascularization between patients treated with bevacizumab
monotherapy with ROP recurrence (0.11 DD/w) and patients
without recurrence (0.23 DD/w) [2]. Although the univariate
analysis showed that numerous factors are associated with
a delay in the speed of retinal vascular development, this
study intends to identify the factors causing the temporal
development of the retina to be <0.5 DD/w. The only
three factors considered to be significant in the multivariate
analysis were incubation days, BPD 3, and weight gain at 4-6
weeks.
Many studies indicate that BPD is associated with the
development of ROP. High oxygen administration in ROP
is a factor that inhibits or delays retinal vascularization [19].
Holmstro¨m et al. showed that BPD precedes ROP and acts
as a risk factor for its development and severity [20]. Other
authors support this theory since premature infants with BPD
require oxygen therapy, which may increase the incidence
of ROP [21–24]. These results are consistent with other
researches confirming that long-term mechanical ventilation
and/or CPAP are risk factors for the development of severe
forms of ROP [15, 25, 26]. The SUPPORT group found that
premature infants with oxygen saturations between 85 and
92% in the first 33 weeks had less delay in vascularization
and less risk of severe ROP than patients with higher oxygen
saturations [27].
BPD is characterized by abnormal alveolar microvascular
development and altered alveolarization. The factors that
dysregulate angiogenesis are common to both ROP and BPD
[23, 28]. The results of our study showed that the intubation
days and BPD 3 were risk factors associated with ROP.
However, BPD caused delayed retinal vascular development
regardless of the intubation time.
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It has been described that adequate energy intake facil-
itates growth and reduces morbidity. This is consistent with
our results because the greater the weight gain, the lower the
risk of BPDandROP [29]. Increasedweight gain at 4-6weeks’
postnatal age acts as a protective factor of ROP as it allows for
appropriate speed of retinal vascularization.
The developmental period of ROP can be shortened by
faster vascularization of the retina. In this study we observe
that the factors that influence the delay in vascularization
and therefore increase the risk of severe ROP are degree 3
of bronchopulmonary dysplasia and intubation days whereas
greater postnatal weight gain favours an appropriate rate of
retinal vascularization.
5. Limitations
The authors who studied the extension of retinal vascular-
ization between 2014 and 2019 do so on fundus photography
or by fluorescein angiography, where they have been able to
repeat measurements in a masked manner. The explorations
in our work were performed by binocular ophthalmoscope
only by a paediatric ophthalmologist on awake children, with
the difficulty that entails. The study covers a long period
of time, between 2000 and 2017; oxygenation protocols in
premature infants were modified so that not all premature
infants were treated with the same oxygen therapy protocols,
as discussed in Section 2.
In conclusion, the rate of vascularization should be an
important factor in the exploration of children with ROP. A
speed of retinal vascularization <0.5DD/w should alert us to
the increased risk of severe ROP. An increased weight gain at
4-6 weeks’ postnatal age is considered as a protective factor
in the speed of retinal vascularization in ROP whereas BPD 3
and greater number of intubation days act as risk factors for
delayed vascular development.
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